JP2020517643A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020517643A5 JP2020517643A5 JP2019556909A JP2019556909A JP2020517643A5 JP 2020517643 A5 JP2020517643 A5 JP 2020517643A5 JP 2019556909 A JP2019556909 A JP 2019556909A JP 2019556909 A JP2019556909 A JP 2019556909A JP 2020517643 A5 JP2020517643 A5 JP 2020517643A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- sequence
- complement
- seq
- amino acids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022159216A JP2022188170A (ja) | 2017-04-21 | 2022-10-03 | 瘢痕性眼炎症障害の治療のためのコバーシン |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1706406.4A GB201706406D0 (en) | 2017-04-21 | 2017-04-21 | Method of treatment |
| GBGB1706398.3A GB201706398D0 (en) | 2017-04-21 | 2017-04-21 | Method of treatment |
| GB1706398.3 | 2017-04-21 | ||
| GB1706406.4 | 2017-04-21 | ||
| PCT/EP2018/060239 WO2018193120A1 (en) | 2017-04-21 | 2018-04-20 | Coversin for the treatment of cicatrising eye inflammatory disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022159216A Division JP2022188170A (ja) | 2017-04-21 | 2022-10-03 | 瘢痕性眼炎症障害の治療のためのコバーシン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020517643A JP2020517643A (ja) | 2020-06-18 |
| JP2020517643A5 true JP2020517643A5 (enExample) | 2021-05-27 |
| JP7153669B2 JP7153669B2 (ja) | 2022-10-14 |
Family
ID=62028030
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019556909A Active JP7153669B2 (ja) | 2017-04-21 | 2018-04-20 | 瘢痕性眼炎症障害の治療のためのコバーシン |
| JP2022159216A Ceased JP2022188170A (ja) | 2017-04-21 | 2022-10-03 | 瘢痕性眼炎症障害の治療のためのコバーシン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022159216A Ceased JP2022188170A (ja) | 2017-04-21 | 2022-10-03 | 瘢痕性眼炎症障害の治療のためのコバーシン |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210113658A1 (enExample) |
| EP (1) | EP3612206A1 (enExample) |
| JP (2) | JP7153669B2 (enExample) |
| KR (1) | KR20190138650A (enExample) |
| CN (1) | CN110831617A (enExample) |
| AU (1) | AU2018253960A1 (enExample) |
| CA (1) | CA3060331A1 (enExample) |
| WO (1) | WO2018193120A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201706406D0 (en) | 2017-04-21 | 2017-06-07 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| US11730792B2 (en) | 2017-04-21 | 2023-08-22 | Volution Immuno Pharmaceuticals Sa | Coversin (OmCI) for the treatment of autoimmune blistering diseases: bullous pemphigoid (BP) and epidermolysis bullosa acquisita (EBA) |
| GB201905810D0 (en) | 2019-04-25 | 2019-06-05 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| US20220370556A1 (en) | 2019-09-27 | 2022-11-24 | Volution Immuno Pharmaceuticals Sa | Method of Treatment |
| WO2023224046A1 (ja) | 2022-05-18 | 2023-11-23 | 旭化成株式会社 | 樹脂組成物の製造方法 |
| GB202218084D0 (en) | 2022-12-01 | 2023-01-18 | Volution Immuno Pharmaceuticals Sa | Fusion proteins |
| GB202408081D0 (en) | 2024-06-06 | 2024-07-24 | Volution Immuno Pharmaceuticals Sa | Methods of removing impurities |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1739078A1 (de) * | 2005-05-30 | 2007-01-03 | Jerini AG | C5a-Rezeptor-Antagonisten |
| PL2061501T3 (pl) * | 2006-09-08 | 2016-01-29 | Volution Immuno Pharmaceuticals Sa | Sposób leczenia zaburzeń oddechowych |
| AU2008228247A1 (en) * | 2007-03-22 | 2008-09-25 | Novartis Ag | C5 antigens and uses thereof |
| GB0802116D0 (en) * | 2008-02-05 | 2008-03-12 | Natural Enviromental Res Counc | Treatment |
| WO2011056972A2 (en) * | 2009-11-04 | 2011-05-12 | Case Western Reserve University | Compositions and methods of treating a t cell mediated disorder |
| GB0906779D0 (en) * | 2009-04-20 | 2009-06-03 | Natural Environment Res Council | Composition |
| US20110077270A1 (en) * | 2009-04-21 | 2011-03-31 | Pfeffer Bruce A | Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure |
| EP3524258B1 (en) * | 2011-06-22 | 2025-10-01 | Apellis Pharmaceuticals, Inc. | Methods of treating chronic disorders with complement inhibitors |
| US20170014487A1 (en) * | 2014-03-04 | 2017-01-19 | The Trustees Of Columbia University In The City Of New York | Method for treating ocular inflammation |
| GB201410031D0 (en) * | 2014-06-05 | 2014-07-16 | Isis Innovation | Polypeptides and uses thereof |
| GB201410116D0 (en) * | 2014-06-06 | 2014-07-23 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| US9937222B2 (en) * | 2015-01-28 | 2018-04-10 | Ra Pharmaceuticals, Inc. | Modulators of complement activity |
| GB201706406D0 (en) * | 2017-04-21 | 2017-06-07 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| US11730792B2 (en) * | 2017-04-21 | 2023-08-22 | Volution Immuno Pharmaceuticals Sa | Coversin (OmCI) for the treatment of autoimmune blistering diseases: bullous pemphigoid (BP) and epidermolysis bullosa acquisita (EBA) |
-
2018
- 2018-04-20 WO PCT/EP2018/060239 patent/WO2018193120A1/en not_active Ceased
- 2018-04-20 CA CA3060331A patent/CA3060331A1/en active Pending
- 2018-04-20 EP EP18719168.9A patent/EP3612206A1/en not_active Withdrawn
- 2018-04-20 US US16/603,354 patent/US20210113658A1/en not_active Abandoned
- 2018-04-20 JP JP2019556909A patent/JP7153669B2/ja active Active
- 2018-04-20 KR KR1020197031685A patent/KR20190138650A/ko not_active Ceased
- 2018-04-20 CN CN201880041705.4A patent/CN110831617A/zh active Pending
- 2018-04-20 AU AU2018253960A patent/AU2018253960A1/en not_active Abandoned
-
2022
- 2022-10-03 JP JP2022159216A patent/JP2022188170A/ja not_active Ceased